https://www.indianpharmapost.com/ema-validates-type-ii-variation-application-for-enfortumab-vedotin-with-pembrolizumab-for-treatment-of-bladder-cancer-152062024-01-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/mercks-keytruda-reduced-the-risk-of-death-by-38-for-patients-with-rcc-152072024-01-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/jubilant-pharmova-singapore-to-sell-its-entire-258-stake-in-sofie-biosciences-usa-152082024-01-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/jiangsu-alphamab-3d-medicines-and-glenmark-sign-license-agreement-for-envafolimab-152092024-01-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/indian-red-cross-society-and-cadila-to-launch-training-of-50000-students-for-cpr-and-first-aid-152112024-01-29T00:00:00+05:30always0.9